AbCellera appoints Sarah Noonberg as first Chief Medical Officer

AbCellera Biologics Inc.

Dr. Sarah Noonberg appointed CMO effective September 10, 2025; she is AbCellera's first CMO.
Noonberg brings over 20 years experience, previously CMO at Metagenomi and other biotechs.
She will lead clinical development of AbCellera's antibody-based therapeutic pipeline.
Appointment marks company transition from discovery to clinical-stage organization.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.